Papers And Originals
Cultivation of a Novel Type of Common-cold Virus in Organ Cultures
Br Med J 1965; 1 doi: https://doi.org/10.1136/bmj.1.5448.1467 (Published 05 June 1965) Cite this as: Br Med J 1965;1:1467Related articles
- No related articles found.
See more
- Contaminated blood victims are still being let down by government, say campaignersBMJ April 19, 2024, 385 q909; DOI: https://doi.org/10.1136/bmj.q909
- Bird flu: Person with rare strain in US sparks alarm about cow transmissionBMJ April 04, 2024, 385 q797; DOI: https://doi.org/10.1136/bmj.q797
- Antibiotic costs rise 1100% as big pharma exits NigeriaBMJ March 01, 2024, 384 q328; DOI: https://doi.org/10.1136/bmj.q328
- Measles: 500 cases are confirmed in England as clusters appear around the countryBMJ February 15, 2024, 384 q417; DOI: https://doi.org/10.1136/bmj.q417
- Alaskapox: First human death from zoonotic virus is announcedBMJ February 15, 2024, 384 q415; DOI: https://doi.org/10.1136/bmj.q415
Cited by...
- Human coronavirus 229E infection inactivates pyroptosis executioner gasdermin D but ultimately leads to lytic cell death partly mediated by gasdermin E
- The FDA-approved drug nitazoxanide is a potent inhibitor of human seasonal coronaviruses acting at postentry level: effect on the viral spike glycoprotein
- Human coronaviruses activate and hijack the proteostasis guardian HSF1 to enhance viral replication
- Nitazoxanide is a potent inhibitor of human seasonal coronaviruses acting at postentry level: effect on viral spike glycoprotein
- The RNA demethylase FTO controls m6A marking on SARS-CoV-2 and classifies COVID-19 severity in patients
- Broad Cross-reactive IgA and IgG Against Human Coronaviruses in Milk Induced by COVID-19 Vaccination and Infection
- A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection
- Disparate temperature-dependent virus - host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium
- Pre-existing T cell-mediated cross-reactivity to SARS-CoV-2 cannot solely be explained by prior exposure to endemic human coronaviruses
- A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease
- SARS-CoV-2 and human milk: what is the evidence?
- Immunological assays for SARS-CoV-2: an analysis of available commercial tests to measure antigen and antibodies
- Scientific output on coronavirus and WHOs Solidarity Project: a science-based choice?
- Human coronaviruses: ophthalmic manifestations
- Near-Physiological-Temperature Serial Femtosecond X-ray Crystallography Reveals Novel Conformations of SARS-CoV-2 Main Protease Active Site for Improved Drug Repurposing
- Covid-19: First coronavirus was described in The BMJ in 1965
- Structural Characterization of Human Coronavirus NL63 N Protein
- Human Coronavirus-Associated Influenza-Like Illness in the Community Setting in Peru
- Isolation and Characterization of Current Human Coronavirus Strains in Primary Human Epithelial Cell Cultures Reveal Differences in Target Cell Tropism
- Culturing the Unculturable: Human Coronavirus HKU1 Infects, Replicates, and Produces Progeny Virions in Human Ciliated Airway Epithelial Cell Cultures
- Human Bocavirus Can Be Cultured in Differentiated Human Airway Epithelial Cells
- Development of a Nucleocapsid-Based Human Coronavirus Immunoassay and Estimates of Individuals Exposed to Coronavirus in a U.S. Metropolitan Population
- The Novel Human Coronaviruses NL63 and HKU1